|
Delayed
London S.E.
|
5-day change | 1st Jan Change | ||
| - GBX | -.--% |
|
+0.65% | -29.32% |
| 14/17/14 | Vernalis : AGM Statement | PU |
| 14/17/14 | Vernalis PLC: AGM Statement | MW |
| 13/17/13 | Vernalis : enters into research collaboration with Daiichi Sankyo | PU |
| 13/17/13 | Vernalis : + Daiichi Sankyo Enter Collaboration | MW |
| 06/17/06 | Vernalis : and Servier Achieve Research Milestone in Third Oncology Collaboration | PU |
| Director | Title | Age | Since |
|---|---|---|---|
Todd Davis
BRD | Director/Board Member | 65 | 05/12/2022 |
Octavio Espinoza
BRD | Director/Board Member | 56 | 01/11/2022 |
Andrew Reardon
BRD | Director/Board Member | 52 | 01/11/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.65% | - | - | 0 | |
| +0.88% | +1.18% | +40.64% | +74.91% | 6.47TCr | |
| -0.26% | +7.23% | +11.14% | +74.78% | 5.48TCr | |
| +0.47% | +5.10% | +8.22% | +101.52% | 5.35TCr | |
| -2.06% | +2.51% | +24.07% | +50.98% | 4.6TCr | |
| -1.79% | +0.49% | +19.32% | +122.77% | 4.29TCr | |
| -1.65% | +3.34% | +237.56% | +819.04% | 4.01TCr | |
| -2.26% | -2.06% | +15.38% | +45.14% | 3.35TCr | |
| +0.22% | -4.77% | +26.59% | +0.55% | 2.4TCr | |
| +12.10% | +18.47% | +55.14% | +45.58% | 2.37TCr | |
| Average | +0.56% | +2.22% | +48.67% | +148.36% | 4.26TCr | |
| Weighted average by Cap. | +0.12% | +2.59% | +45.92% | +149.88% |
- Stock Market
- Stocks
- VER Stock
Select your edition
All financial news and data tailored to specific country editions
